Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study | PLOS ONE
![The translation of genetic breast cancer screening into the clinic: current challenges and potential benefits – The MedGen Project The translation of genetic breast cancer screening into the clinic: current challenges and potential benefits – The MedGen Project](https://uoftmedicalgenomicshome.files.wordpress.com/2020/04/group-7-figure-2.png?w=886)
The translation of genetic breast cancer screening into the clinic: current challenges and potential benefits – The MedGen Project
![Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry | Breast Cancer Research Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry | Breast Cancer Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-021-01399-7/MediaObjects/13058_2021_1399_Fig2_HTML.png)
Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry | Breast Cancer Research
![A systematic review and quality assessment of individualised breast cancer risk prediction models | British Journal of Cancer A systematic review and quality assessment of individualised breast cancer risk prediction models | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-019-0476-8/MediaObjects/41416_2019_476_Fig1_HTML.png)
A systematic review and quality assessment of individualised breast cancer risk prediction models | British Journal of Cancer
![Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation - ScienceDirect Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S104084282200066X-ga1.jpg)
Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation - ScienceDirect
Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial
![BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface | British Journal of Cancer BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fbjc.2013.730/MediaObjects/41416_2014_Article_BFbjc2013730_Fig3_HTML.jpg)
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface | British Journal of Cancer
BREAst screening Tailored for HEr (BREATHE)—A study protocol on personalised risk-based breast cancer screening programme | PLOS ONE
![It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn](https://cdn.mdedge.com/files/s3fs-public/obgm03210-pearlman_web_t1.jpg)
It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn
![Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence | Journal of Medical Genetics Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence | Journal of Medical Genetics](https://jmg.bmj.com/content/jmedgenet/59/12/1206/F4.large.jpg)
Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence | Journal of Medical Genetics
![BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface | British Journal of Cancer BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2013.730/MediaObjects/41416_2014_Article_BFbjc2013730_Fig1_HTML.jpg)
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface | British Journal of Cancer
Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study | PLOS ONE
![Genes | Free Full-Text | Germline Testing in a Cohort of Patients at High Risk of Hereditary Cancer Predisposition Syndromes: First Two-Year Results from South Italy Genes | Free Full-Text | Germline Testing in a Cohort of Patients at High Risk of Hereditary Cancer Predisposition Syndromes: First Two-Year Results from South Italy](https://pub.mdpi-res.com/genes/genes-13-01286/article_deploy/html/images/genes-13-01286-g001.png?1658384682)